Global 3D Bioprinting for Life Science R&D Market Growth (Status and Outlook) 2023-2029

Global 3D Bioprinting for Life Science R&D Market Growth (Status and Outlook) 2023-2029

3D printing first got widespread public attention in 2013, when it was specifically mentioned by President Obama in his State of the Union Address. 3D printing is a manufacturing process where an object is created with the help of a layer-by-layer material approach. Each layer can be considered a thin horizontal cross-section of the final product. It uses Computer Aided Design (CAD) i.e. a digital blueprint to create rapid prototypes, spare parts and final products. 3D printing uses materials like thermoplastics, plastic composites, metals, alloys, ceramics etc. 3D printing as an end-use manufacturing technology is still not fully developed but it has the potential to transform the conception, manufacturing and logistics processes.

LPI (LP Information)' newest research report, the “3D Bioprinting for Life Science R&D Industry Forecast” looks at past sales and reviews total world 3D Bioprinting for Life Science R&D sales in 2022, providing a comprehensive analysis by region and market sector of projected 3D Bioprinting for Life Science R&D sales for 2023 through 2029. With 3D Bioprinting for Life Science R&D sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 3D Bioprinting for Life Science R&D industry.

This Insight Report provides a comprehensive analysis of the global 3D Bioprinting for Life Science R&D landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 3D Bioprinting for Life Science R&D portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 3D Bioprinting for Life Science R&D market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 3D Bioprinting for Life Science R&D and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 3D Bioprinting for Life Science R&D.

The global 3D Bioprinting for Life Science R&D market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

The drug testing market is likely to be the main driver of the 3D Bioprinting for Life Science R&D Market. Since 2011, a group of U.S government agencies have been investing in something known as ‘Human on a chip’ or ‘Body on a chip’. The objective is to create a miniature human organ system that mimics the bodily response to harmful agents, enabling the development of potential therapies. The pharmaceutical industry could use such equipment to test drugs more efficiently due to human stem cells and at a much lower cost. It would also be less risky.

This report presents a comprehensive overview, market shares, and growth opportunities of 3D Bioprinting for Life Science R&D market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Magnetic 3D Bioprinting
Laser-Assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting

Segmentation by application
Clinical
Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
EnvisionTEC
Regenovo
Organovo
3D Systems
3D Biotek
Advanced Biomatrix
Digilab
Nano3D Biosciences

Please note: The report will take approximately 2 business days to prepare and deliver.